These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

744 related items for PubMed ID: 17971817

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
    Emini EA, Koff WC.
    Science; 2004 Jun 25; 304(5679):1913-4. PubMed ID: 15218131
    [No Abstract] [Full Text] [Related]

  • 3. AIDS vaccine development: the long and winding road.
    Garber DA, Feinberg MB.
    AIDS Rev; 2003 Jun 25; 5(3):131-9. PubMed ID: 14598562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Subtype AE HIV-1 DNA and recombinant Fowlpoxvirus vaccines encoding five shared HIV-1 genes: safety and T cell immunogenicity in macaques.
    De Rose R, Chea S, Dale CJ, Reece J, Fernandez CS, Wilson KM, Thomson S, Ramshaw IA, Coupar BE, Boyle DB, Sullivan MT, Kent SJ.
    Vaccine; 2005 Mar 14; 23(16):1949-56. PubMed ID: 15734067
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
    Wingard JB, Anderson B, Weissman D.
    Eur J Immunol; 2008 May 14; 38(5):1310-20. PubMed ID: 18412164
    [Abstract] [Full Text] [Related]

  • 11. [Vaccines against HIV].
    Holm-Hansen C.
    Tidsskr Nor Laegeforen; 2006 Nov 30; 126(23):3117-20. PubMed ID: 17160118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
    Huang Y, Chen A, Li X, Chen Z, Zhang W, Song Y, Gurner D, Gardiner D, Basu S, Ho DD, Tsuji M.
    Vaccine; 2008 Mar 28; 26(15):1807-16. PubMed ID: 18329757
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.
    Hinkula J.
    Expert Rev Vaccines; 2007 Apr 28; 6(2):203-12. PubMed ID: 17408370
    [Abstract] [Full Text] [Related]

  • 18. [The quest for an HIV vaccine].
    Girard MP.
    Bull Acad Natl Med; 2005 May 28; 189(5):831-44; discussion 844. PubMed ID: 16433455
    [Abstract] [Full Text] [Related]

  • 19. [Study on the immunogenicity of HIV-1 gag vaccine].
    Jiang WZ, Jin NY, Li ZJ, Zhang LS.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May 28; 20(3):272-3. PubMed ID: 15193215
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.